semaglutide with thyroid issues and Health: What Patients Should Know Semaglutide and Hypothyroidism | Nulevel

Semaglutide programs are designed for safe, effective, and medically supervised weight loss

For instance, the outcomes of semaglutide and liraglutide in patients with DM2 have shown a cardiovascular risk factors reduction and an improvement in glucose levels and nutritional status (22, 58, 6163)

These medications have been approved by regulatory authorities specifically for obesity treatment and have shown significant weight loss benefits in clinical trials

In the landmark STEP clinical trial program, semaglutide produced an average weight loss of 14.9% of body weight over 68 weeks a level of efficacy that had previously only been achievable through bariatric surgery